etiolog
multipl
sclerosi
ms
remain
elus
howev
clue
pathogenesi
tradit
deriv
basic
patholog
character
central
nervou
system
cn
tissu
ms
patient
ongo
debat
linger
autoimmun
natur
ms
well
establish
immun
system
directli
particip
destruct
myelin
nervou
cell
understand
mechan
immunemedi
destruct
cn
compon
ms
promis
promot
effect
design
ms
therapeut
also
provid
broader
understand
immunemedi
diseas
affect
cn
review
explor
principl
featur
immunopatholog
ms
particular
relapsingremit
ms
rrm
herein
emerg
concept
pathogenesi
ms
context
known
featur
patholog
highlight
includ
character
cytokin
network
promot
inflammatori
damag
cn
b
cell
involv
inflammatori
damag
axon
neuron
effort
made
preferenti
focu
ms
rather
anim
model
diseas
experiment
autoimmun
encephalomyel
eae
comprehens
examin
data
deriv
studi
anim
model
reader
refer
outstand
review
human
studi
alon
clear
past
year
highli
product
advanc
understand
pathogenesi
ms
gener
neurologist
ms
specialist
fundament
appreci
immunopatholog
ms
lead
broader
understand
diseas
cours
emerg
ms
therapeut
ever
tailor
intricaci
immun
system
plaqu
inflammatori
demyelin
within
cn
patholog
hallmark
ms
myelin
destruct
essenti
element
plaqu
yet
ms
plaqu
simpli
static
entiti
myelin
loss
isol
rather
lesion
compris
wide
variat
immunolog
patholog
featur
featur
categor
effort
understand
neuralimmun
mechan
underli
ms
construct
etiolog
multipl
sclerosi
ms
remain
elus
howev
clue
pathogenesi
tradit
deriv
basic
patholog
character
central
nervou
system
cn
tissu
ms
patient
ongo
debat
linger
autoimmun
natur
ms
well
establish
immun
system
directli
particip
destruct
myelin
nervou
cell
understand
mechan
immunemedi
destruct
cn
compon
ms
promis
promot
effect
design
ms
therapeut
also
provid
broader
understand
immunemedi
diseas
affect
cn
review
explor
principl
featur
immunopatholog
ms
particular
relapsingremit
ms
rrm
herein
emerg
concept
pathogenesi
ms
context
known
featur
patholog
highlight
includ
character
cytokin
network
promot
inflammatori
damag
cn
b
cell
involv
inflammatori
damag
axon
neuron
effort
made
preferenti
focu
ms
rather
anim
model
diseas
experiment
autoimmun
encephalomyel
eae
comprehens
examin
data
deriv
studi
anim
model
reader
refer
outstand
review
human
studi
alon
clear
past
year
highli
product
advanc
understand
pathogenesi
ms
gener
neurologist
ms
specialist
fundament
appreci
immunopatholog
ms
lead
broader
understand
diseas
cours
emerg
ms
therapeut
ever
tailor
intricaci
immun
system
plaqu
inflammatori
demyelin
within
cn
patholog
hallmark
ms
myelin
destruct
essenti
element
plaqu
yet
ms
plaqu
simpli
static
entiti
myelin
loss
isol
rather
lesion
compris
wide
variat
immunolog
patholog
featur
featur
categor
effort
understand
neuralimmun
mechan
underli
ms
construct
framework
around
myelin
loss
neuronalaxon
injuri
occur
entail
close
examin
cellular
molecular
constitu
time
damag
repair
process
thu
variou
featur
plaqu
provid
platform
hypothes
regard
pathogen
mechan
underli
ms
formul
centuri
tradit
ms
plaqu
classif
base
tempor
progress
stage
inflammatori
destruct
accordingli
acut
chronic
activ
chronic
silent
lesion
thought
occur
along
continu
timelin
eventu
produc
scar
harden
area
within
cn
appreci
grossli
figur
acut
ms
plaqu
repres
earliest
stage
lesion
format
typifi
robust
inflammatori
infiltr
combin
demyelin
distribut
throughout
lesion
figur
typic
featur
acut
plaqu
includ
illdefin
margin
myelin
loss
infiltr
immun
cell
parenchym
edema
constitu
immun
cell
influx
center
around
vessel
term
perivascular
cuf
includ
lymphocyt
predominantli
cell
monocyt
macrophag
portion
major
histocompat
class
ii
mhcii
express
cell
distribut
evenli
throughout
lesion
load
lipid
foami
macrophag
figur
particip
activ
strip
myelin
axon
oligodendrocyt
apoptosi
observ
degre
oligodendrocyt
loss
within
activ
lesion
variabl
spite
rel
degre
axon
spare
axon
injuri
extens
acut
lesion
see
section
glial
reactiv
throughout
lesion
note
particularli
hypertroph
astrocyt
howev
dens
glial
scar
typic
acut
plaqu
chronic
plaqu
character
region
hypocellular
loss
myelin
glial
scar
gross
examin
postmortem
tissu
harden
discolor
appear
chronic
plaqu
often
appreci
frequent
target
area
cn
eg
corpu
callosum
figur
histolog
lesion
border
chronic
plaqu
distinct
acut
plaqu
figur
divis
two
form
chronic
plaqu
made
signifi
tempor
evolut
activ
destruct
edg
lesion
chronic
activ
plaqu
entir
burn
lesion
devoid
activ
inflammatori
destruct
chronic
silent
plaqu
chronic
activ
lesion
inflamm
continu
along
outer
border
histolog
appear
compar
acut
lesion
thu
border
chronic
activ
plaqu
popul
activ
microglia
macrophag
vessel
demonstr
perivascular
cuf
reactiv
astrocyt
presenc
antibodi
complement
promin
chronic
activ
lesion
area
remyelin
often
observ
edg
lesion
encompass
entir
lesion
core
chronic
plaqu
typic
hypocellular
though
often
contain
thicken
vessel
enlarg
perivascular
space
chronic
silent
lesion
character
loss
inflammatori
trait
along
border
chronic
activ
lesion
remyelin
presenc
oligodendrocyt
progenitor
uncommon
essenti
chronic
silent
plaqu
burn
contain
minim
inflamm
devoid
activ
inflammatori
border
accompani
complet
loss
oligodendrocyt
variabl
demonstr
reduct
axon
densiti
figur
overal
gross
histolog
featur
ms
plaqu
impli
complex
progress
inflammatori
damag
culmin
scar
region
demyelin
extens
variabl
across
ms
plaqu
exist
includ
differ
degre
inflamm
demyelin
remyelin
axon
injuri
controversi
emerg
taxonomi
lesion
group
possibl
part
result
studi
combin
autopsi
biopsi
tissu
differ
stage
diseas
rel
recent
attempt
made
redefin
process
categor
ms
lesion
propos
system
classif
base
suspect
patholog
mechan
alongsid
temporallybas
system
lucchinetti
et
al
describ
variou
type
lesion
base
pattern
leukocyt
marker
myelin
protein
immunoglobulin
complement
within
lesion
patholog
specimen
obtain
autopsi
biopsi
four
distinct
pattern
immunolog
patholog
featur
activ
demyelin
lesion
discern
pattern
ii
iii
common
pattern
character
predomin
cell
macrophag
inflammatori
content
pattern
ii
character
cell
macrophag
infiltr
along
accentu
immunoglobulin
deposit
myelin
degrad
product
within
macrophag
pattern
iii
distinguish
pronounc
oligodendrocyt
loss
activ
edg
lesion
preferenti
loss
myelinassoci
glycoprotein
mag
pattern
iv
character
oligodendrocyt
dystrophi
absenc
remyelin
shadow
plaqu
importantli
distinct
pattern
consist
observ
within
sampl
patient
vari
patient
author
base
result
one
openlabel
clinic
trial
patient
brain
biopsi
hypothes
deficit
recoveri
plasma
exchang
indic
individu
pattern
ms
patholog
plasma
exchang
effect
patient
biopsyproven
pattern
ii
promin
antibodi
complement
involv
patient
pattern
iii
lesion
overal
categor
ms
lesion
base
immunopatholog
mechan
ad
complex
paradigm
lesion
classif
thought
distinct
patholog
process
underli
singular
clinic
entiti
refer
ms
attract
concept
recent
disput
particular
challeng
emerg
idea
clear
delin
differ
pattern
patholog
prinea
colleagu
report
acut
lesion
patient
consist
featur
sever
four
patholog
pattern
furthermor
recent
studi
tissu
specimen
ms
patient
lesion
littl
interindividu
variat
patholog
featur
inde
lesion
studi
exhibit
trait
consist
inclus
pattern
ii
ie
deposit
complement
antibodi
proxim
macrophag
absenc
oligodendrocyt
apoptosi
therefor
variou
patholog
pattern
diseas
may
precis
refer
stage
lesion
relev
classif
system
base
four
individu
subtyp
plaqu
remain
confirm
time
lesion
evalu
may
one
critic
factor
reconcil
conflict
data
describ
one
hypothesi
propos
regard
initi
event
plaqu
genesi
earli
intrins
oligodendrocyt
injuri
lead
inflammatori
damag
histor
associ
patholog
featur
ms
plaqu
thu
toxic
insult
directli
affect
oligodendrocyt
could
serv
trigger
common
immunopatholog
pathway
associ
evolut
later
stage
plaqu
case
examin
breij
et
al
patient
progress
phase
diseas
would
suggest
earli
heterogen
lesion
could
miss
support
hypothesi
come
studi
activ
lesion
examin
patient
autopsi
earli
cours
diseas
studi
tissu
immedi
adjac
lesion
border
show
microscop
evid
cellular
injuri
without
presenc
immun
infiltr
prinea
colleagu
specul
possibl
toxic
factor
diffus
edg
lesion
result
oligodendrocyt
fragil
refer
area
initi
injuri
prephagocyt
therefor
critic
question
remain
field
neuropatholog
whether
differ
exist
border
acut
versu
chronic
activ
lesion
work
requir
order
clearli
identifi
white
matter
within
cn
undergo
earli
chang
risk
relat
featur
describ
establish
ms
plaqu
longstand
interest
earli
white
matter
chang
ms
earliest
studi
myelin
examin
tissu
outsid
plaqu
region
appear
grossli
unaffect
recent
investig
normal
appear
white
matter
nawm
defin
convent
mri
sequenc
explor
extens
use
varieti
novel
neuroimag
techniqu
show
abnorm
area
suggest
decreas
myelin
integr
diminish
axon
densiti
within
nonlesion
region
histopatholog
examin
nawm
patient
ms
also
support
concept
area
outsid
plaqu
immunopatholog
chang
microgli
activ
cell
infiltr
perivascular
cuf
report
nawm
surprisingli
featur
found
diffus
case
progress
ms
transit
zone
dirti
appear
white
matter
dawm
defin
mri
intermedi
signal
intens
nawm
lesion
show
diffus
loss
myelin
histolog
thu
greater
involv
nawm
ms
associ
progress
diseas
may
relat
extent
inflamm
extend
beyond
focal
lesion
overal
extent
white
matter
abnorm
immunopatholog
featur
nawm
yet
precis
defin
ms
plaqu
confin
white
matter
gray
matter
lesion
detect
mri
examin
patholog
specimen
almost
gray
matter
nuclei
within
cn
affect
observ
cohort
mostli
progress
ms
patient
sever
region
cn
includ
motor
cortex
spinal
cord
cerebellum
particularli
vulner
result
demyelin
gray
matter
averag
might
expect
inflammatori
lesion
within
gray
matter
associ
neuron
loss
transect
axon
common
activ
lesion
gray
matter
lesion
seem
common
patient
progress
form
ms
develop
earli
diseas
process
possibl
account
disabl
seen
ms
patient
explain
white
matter
lesion
exampl
lesion
locat
within
gray
matter
correl
better
cognit
disabl
white
matter
lesion
sever
uniqu
featur
patholog
associ
gray
matter
lesion
histolog
gray
matter
lesion
less
inflammatori
fewer
infiltr
tlymphocyt
microgliamacrophag
pure
cortic
gray
matter
lesion
also
describ
lack
complement
deposit
bloodbrain
barrier
breakdown
whether
gray
matter
plaqu
aris
distinct
immunolog
mechan
unclear
time
attempt
care
evalu
process
involv
cortic
lesion
separ
sever
categori
base
depth
penetr
surfac
brain
figur
type
lesion
includ
discern
injuri
white
gray
matter
type
ii
lesion
perivascular
area
demyelin
isol
cortex
type
iii
lesion
demonstr
cortic
demyelin
pial
surfac
often
cover
sever
gyri
stop
cortic
layer
three
four
other
propos
fourth
categori
type
iv
describ
lesion
affect
cortic
layer
without
extend
white
matter
figur
type
iii
iv
lesion
extens
difficult
visual
although
scarc
inflammatori
cell
found
within
lesion
mening
overli
contain
inflammatori
cell
collect
structur
resembl
ectop
bcell
follicl
support
role
lymphoid
neogenesi
pathogenesi
lesion
patient
ectop
bcell
follicl
secondari
progress
ms
patient
rapid
diseas
progress
solid
determin
role
ectop
b
cell
follicl
format
ms
depend
upon
reliabl
detect
cortic
lesion
mri
identif
immunopatholog
mechan
lead
lymphoid
neogenesi
within
cn
lymphocyt
presenc
within
plaqu
border
area
suggest
inflammatori
destruct
ms
driven
antigenspecif
target
myelin
cn
compon
particular
adapt
immun
respons
lymphocyt
thought
mediat
injuri
myelin
nerv
within
cn
ms
determin
eae
mediat
cell
promot
intens
investig
potenti
cell
target
ms
relev
antigenspecif
cell
respons
ms
highlight
result
trial
use
alter
peptid
ligand
mbp
design
therapeut
suppress
cell
respons
result
diseas
exacerb
multipl
patient
cell
ms
patient
recogn
varieti
myelin
protein
target
includ
mbp
plp
mog
mobp
among
other
nonmyelin
cell
antigen
also
describ
includ
crystallin
neuron
protein
autoreact
cell
also
observ
although
similar
frequenc
autoreact
cell
found
ms
patient
healthi
subject
myelinspecif
cell
avid
activ
profil
appear
elev
ms
patient
newer
technolog
array
protein
lipid
gene
express
allow
fresh
insight
target
heretofor
unknown
exampl
highli
express
gene
ms
plaqu
compar
nonlesion
cn
tissu
includ
osteopontin
howev
elev
gene
express
necessarili
impli
target
adapt
immun
respons
ms
gene
encod
myelin
protein
actual
display
reduc
express
thu
sever
target
valid
eae
involv
ms
yet
fulli
demonstr
like
multipl
cn
antigen
exist
cell
inflammatori
target
ms
result
array
experi
highlight
divers
extens
target
may
cell
becom
abnorm
activ
toward
cn
antigen
remain
unclear
popular
concept
invok
explain
cell
becom
pathogen
ms
patient
molecular
mimicri
sever
infecti
agent
postul
serv
activ
trigger
autoreact
cell
consist
report
one
epstein
barr
viru
ebv
infecti
agent
may
also
serv
trigger
crossreact
myelin
compon
one
advantag
adapt
immun
respons
ms
lie
abil
har
specif
cell
respons
discret
immunolog
target
therapi
may
avail
treat
ms
includ
vaccin
antigen
present
cell
apc
mediat
deliveri
antigen
design
induc
antigenspecif
toler
clearli
antigenspecif
therapeut
ms
must
address
potenti
wide
array
cell
target
well
hlaspecif
present
antigen
intrins
genet
heterogen
individu
ms
sinc
identif
novel
cytokin
intens
inquiri
role
eae
ms
taken
place
two
member
gene
famili
express
cell
cua
colleagu
identifi
critic
cytokin
regul
eae
quickli
led
new
pathway
investig
immunolog
basi
ms
discoveri
regul
product
cell
subsequ
cell
emerg
distinct
lineag
helper
cell
term
cell
eae
cell
particip
earli
infiltr
cn
alon
induc
uniqu
neutrophilpredomin
patholog
howev
unlik
neutral
genet
delet
eae
result
complet
absenc
diseas
henc
direct
contribut
cell
autoimmun
demyelin
remain
unclear
human
studi
emerg
bolster
relev
pathogenesi
ms
greater
proport
cell
cell
found
csf
ms
patient
compar
noninflammatori
neurolog
diseas
percentag
memori
cell
elev
peripher
blood
ms
patient
experienc
relaps
addit
cell
adept
kill
human
neuron
vitro
unactiv
cell
provid
entic
data
suggest
cell
potenti
mediat
axon
neuron
damag
ms
lesion
initi
studi
support
idea
cell
may
critic
mediat
immun
destruct
myelin
axon
ms
recent
data
highlight
potenti
target
cell
ms
cell
healthi
individu
skew
produc
respons
one
current
form
treatment
ms
ms
patient
inhibit
differenti
naiv
cell
cell
patient
respons
may
relat
level
prior
onset
therapi
result
reemphas
complex
heterogen
diseas
particular
respons
current
therapi
may
signifi
differ
pathogenesi
ms
patient
pathway
offer
new
therapeut
target
includ
molecular
pathway
regul
howev
consist
complex
cytokin
network
regul
singular
stanc
pure
pathogen
like
oversimplif
particular
may
particip
limit
tissu
destruct
inflammatori
respons
overal
evid
mount
suggest
cell
present
inflammatori
destruct
tissu
ms
question
remain
direct
contribut
newli
identifi
lineag
cell
point
reason
inclus
cell
pathogenesi
ms
figur
degre
involv
remain
shown
evid
gather
examin
cn
tissu
implic
role
antibodi
pathogenesi
ms
note
presenc
plasma
cell
ig
complement
typic
featur
ms
plaqu
natur
observ
prompt
consider
whether
ig
present
within
plaqu
specif
target
myelin
antigen
molecular
featur
b
cell
found
within
ms
plaqu
demonstr
b
cell
receptor
gene
modifi
specif
way
indic
evolv
respons
toward
specif
target
specif
ig
ms
tissu
describ
mbpreactiv
mogreact
ig
isol
cn
tissu
patient
ms
addit
situ
deposit
mogspecif
antibodi
detect
ms
lesion
along
mogand
mbpspecif
ig
complex
myelin
within
macrophag
contrast
detect
ig
appear
nonspecif
dispers
throughout
cellular
constitu
plaqu
nawm
without
signific
differ
compar
control
tissu
suggest
ig
presenc
may
secondari
white
matter
injuri
rather
antigenspecif
b
cell
activ
uniqu
ms
thu
controversi
persist
antigenspecif
natur
b
cell
involv
ms
presenc
plasma
cell
ig
continu
fuel
investig
involv
ms
plaqu
develop
represent
b
cell
involv
cn
parenchym
damag
ms
patient
csf
analysi
afford
sever
clue
role
ig
pathogenesi
ms
local
intrathec
product
ig
refer
oligoclon
band
ocb
detect
patient
rrm
absenc
associ
reduc
sever
diseas
ocb
thought
product
clonallyexpand
b
cell
within
csf
compart
potenti
target
remain
elus
plasma
cell
csf
patient
inflammatori
demyelin
diseas
produc
antibodi
capabl
bind
myelin
recogn
mbp
howev
recent
studi
csf
patient
ms
fail
detect
igg
csf
clonal
b
cell
bound
mbp
plp
mog
analysi
ocb
also
includ
investig
igm
found
subset
ms
patient
csfrestrict
igm
isol
ms
patient
found
target
varieti
lipid
antigen
predominantli
phosphatidylcholin
persist
lipidspecif
igm
ocb
associ
aggress
diseas
might
associ
poor
respons
interferon
therapi
taken
whole
multitud
potenti
target
includ
myelin
well
cn
antigen
propos
investig
patient
ms
review
reindl
colleagu
appear
independ
antibodi
effect
sinc
treatment
directli
target
igsecret
plasma
cell
result
earli
efficaci
relaps
reduct
inflammatori
mri
lesion
alter
csf
ig
level
b
cell
may
promot
neuroinflamm
ms
via
direct
indirect
effect
cell
secret
proinflammatori
cytokin
exampl
b
cell
ms
patient
produc
lymphotoxin
presenc
cellderiv
proinflammatori
cytokin
compar
healthi
control
follow
b
cell
deplet
rrm
patient
cell
produc
less
less
prolif
respons
tcr
engag
convers
b
cell
like
also
immunesuppress
trait
import
immunopathogenesi
ms
exampl
secret
b
cell
serv
limit
proinflammatori
autoreact
cell
respons
found
approxim
autopsi
specimen
patient
spm
presenc
follicl
purport
maker
cortic
lesion
immedi
adjac
ectop
follicl
within
mening
find
disput
subsequ
work
fail
detect
mening
follicl
patient
spm
interestingli
may
associ
presenc
ebv
infecti
materi
secondari
lymphoid
follicl
observ
ms
patient
implic
find
latent
infect
b
cell
ebv
drive
expans
matur
b
cell
along
ectop
follicl
gener
within
cn
promot
intrathec
ig
product
target
destruct
underli
myelin
region
observ
patient
spm
possibl
gener
lymphoid
organlik
structur
begin
relapsingremit
phase
evolv
time
whether
structur
inhibit
b
celldeplet
therapi
ms
remain
investig
immun
access
cn
gener
consid
restrict
practic
tradit
view
cn
immun
privileg
site
replac
appropri
character
cn
immun
special
organ
thu
one
key
element
immunemedi
damag
within
cn
ms
process
immun
cell
abl
gain
access
special
compart
within
context
univers
process
govern
immun
cell
traffick
featur
rel
specif
leukocyt
migrat
within
brain
spinal
cord
health
diseas
molecular
compon
locat
time
migrat
import
factor
immunopathogenesi
ms
bbb
serv
activ
restrict
cellular
macromolecular
movement
blood
cn
tissu
adequ
function
bbb
depend
upon
sever
uniqu
anatom
cellular
featur
includ
tight
junction
endotheli
cell
special
express
molecular
transport
placement
immun
cell
within
cn
rel
vasculatur
engag
critic
time
sequenc
event
autoreact
lymphocyt
abl
enter
cn
compart
initi
leukocyt
engag
roll
activ
arrest
endothelium
bbb
greatli
facilit
upregul
adhes
molecul
vasculatur
includ
trigger
vascular
chang
remain
unclear
ms
hypothet
chang
vascular
endothelium
could
result
proinflammatori
mediat
circul
within
vasculatur
includ
tnf
andor
lp
subsequ
migrat
cell
endotheli
cell
take
place
eventu
concentr
extravas
immun
cell
perivascular
cuff
within
cn
parenchyma
culmin
breach
bbb
essenti
compon
process
inflammatori
destruct
white
matter
ms
complex
set
molecul
leukocyt
depend
upon
entri
cn
tissu
involv
integrin
integrin
heterodimer
cell
surfac
molecul
mediat
adhes
cell
panel
leukocyt
adhes
receptor
subunit
identifi
crucial
factor
encephalitogen
cell
bind
cn
endothelium
blockad
engag
one
bind
partner
success
abrog
diseas
anim
model
ms
clinic
trial
human
monoclon
antibodi
target
subunit
call
natalizumab
also
demonstr
efficaci
treatment
ms
henc
select
inhibit
specif
adhes
molecul
effect
reduc
leukocyt
entri
cn
note
natalizumab
reduc
influx
wide
rang
leukocyt
includ
cell
dendrit
cell
dc
addit
traffick
molecul
impart
specif
migrat
cn
recent
shown
local
bbb
upregul
activ
ms
lesion
experiment
anim
system
blockad
delay
diseas
addit
osteopontin
also
serv
bind
partner
potenti
serv
separ
target
reduc
leukocyt
migrat
cn
patient
ms
henc
multitud
adhes
molecul
particip
effect
leukocyt
traffick
within
cn
serv
potenti
target
therapi
ms
chemokin
broad
class
cytokin
mediat
chemotaxi
also
contribut
leukocyt
migrat
cn
sever
chemokin
receptor
implic
leukocyt
influx
cn
ms
exampl
constitut
express
cn
typic
local
basolater
aspect
cn
microvasculatur
function
retain
leukocyt
within
perivascular
space
redistribut
lumin
aspect
vessel
observ
autopsi
specimen
ms
patient
would
allow
dissemin
lymphocyt
cn
parenchyma
chemokin
thought
particip
recruit
lymphocyt
cn
ms
recent
work
eae
system
demonstr
initi
wave
cell
infiltr
cn
prior
diseas
onset
furthermor
eae
initi
wave
inflammatori
cell
express
potenti
recruit
specif
via
cn
via
choroid
plexu
express
ligand
result
yet
convincingli
replic
human
sampl
sever
chemokin
chemokin
receptor
express
variou
cell
type
ms
show
dysregul
includ
thu
may
uniqu
chemokin
signatur
differ
phase
diseas
differ
region
cn
order
variou
leukocyt
local
cn
ms
antigen
present
cell
apc
process
present
antigen
cell
context
mhc
costimulatori
signal
cytokin
secret
drive
adapt
immun
respons
experiment
evid
base
anim
model
shown
antigenspecif
encount
within
cn
cell
apc
crucial
unfold
ms
eae
without
newli
gener
myelin
antigen
cn
apc
inflammatori
demyelin
proceed
even
presenc
myelinreact
cell
thu
cellmedi
diseas
thought
multistag
process
involv
initi
activ
autoreact
cell
well
reactiv
within
cn
immun
compart
dc
thought
major
apc
secondari
phase
cognat
interact
cell
within
cn
perivascular
space
within
area
border
edg
activ
lesion
contain
immnostain
marker
subset
dc
suggest
antigen
present
dc
interfac
bbb
contribut
earliest
inflammatori
process
promot
lesion
format
visual
apc
interact
encephalitogen
cell
use
intravit
microscopi
rat
model
ms
suggest
prime
cell
activ
engag
perivascular
apc
en
rout
entri
within
cn
addit
dc
apc
like
play
import
role
antigen
present
pathogenesi
ms
microglia
hematogenouslyderiv
resid
apc
within
cn
upon
activ
express
greater
amount
mhcii
costimulatori
molecul
signifi
greater
capac
promot
proinflammatori
cell
respons
within
cn
activ
microglia
local
activ
plaqu
experiment
imped
microgli
function
attenu
eae
howev
rel
profession
apc
microglia
potent
induc
autoreact
cell
respons
may
even
downregul
cell
function
thu
resid
apc
within
cn
microglia
capabl
perform
apc
function
like
lynchpin
drive
autoimmun
cn
ms
anoth
apc
potenti
involv
drive
myelinreact
cell
ms
b
cell
alreadi
mention
recent
work
suggest
b
cell
play
promin
role
pathogenesi
ms
potenti
play
import
role
antigen
present
cell
addit
effect
cell
mhciidepend
interact
b
cell
promot
ig
class
switch
igm
igg
thu
antigenspecif
interact
b
cell
cell
repres
critic
step
gener
ig
respons
ms
import
acknowledg
interact
apc
cell
promot
inflamm
addit
effect
regulatori
b
cell
mention
apc
also
engend
antiinflammatori
respons
exampl
suppressor
myeloid
cell
gener
eae
induct
capabl
suppress
cell
function
ms
process
myeloid
suppress
thought
regul
part
transmembran
signal
protein
express
microgli
cell
macrophag
monocyt
dc
mechan
may
dysregul
secret
solubl
could
act
decoy
receptor
prevent
inhibitori
function
transmembran
inflammatori
cn
injuri
ms
increasingli
associ
axon
damag
although
ms
classic
describ
diseas
mark
loss
myelin
greater
proport
loss
axon
axon
damag
note
earliest
patholog
descript
ms
lesion
modern
techniqu
allow
precis
demonstr
axon
damag
antibodi
direct
amyloid
precursor
protein
show
damag
axon
activ
area
ms
lesion
repres
major
advanc
field
ms
patholog
trapp
et
al
abl
directli
view
quantifi
transect
axon
use
confoc
microscopi
count
axon
ovoid
end
transect
axon
activ
area
ms
lesion
found
contain
transect
axon
inact
area
chronic
lesion
note
comparison
biopsi
autopsi
sampl
patient
relapsingremit
secondari
progress
primari
progress
ms
suggest
axon
patholog
greatest
within
first
year
diseas
onset
particularli
patient
rrm
studi
propos
axon
patholog
occur
area
activ
inflammatori
demyelin
earli
cours
diseas
addit
slower
rate
axon
damag
also
thought
occur
contribut
clinic
declin
observ
ms
patient
trapp
et
al
mechan
involv
axon
damag
ms
intens
investig
tlymphocyt
caus
axon
damag
via
releas
cytotox
granul
induct
apoptosi
activ
surfac
receptor
fa
releas
cytokin
direct
transect
axon
macrophagesmicroglia
also
found
close
proxim
damag
neuron
releas
toxic
molecul
cell
proteas
reactiv
nitrogen
speci
caus
oligodendrocyt
injuri
demyelin
axon
degener
disrupt
bloodbrain
barrier
contribut
loss
axon
conduct
axon
damag
also
occur
activ
compon
innat
immun
respons
tolllik
receptor
tolllik
receptor
overexpress
oligodendrocyt
ms
lesion
inhibit
remyelin
antibodymedi
injuri
axon
compon
eg
neurofascin
result
axon
neuron
dysfunct
consequ
immun
injuri
myelin
higher
energi
demand
demyelin
axon
glutamatemedi
excitotox
may
impart
unsustain
damag
overal
axon
injuri
ms
like
mediat
multipl
mechan
play
activ
chronic
lesion
neuron
loss
ms
sever
occur
throughout
brain
neuron
loss
rang
report
cortex
hippocampu
thalamu
spinal
cord
review
damag
axon
neuron
evalu
vivo
use
mri
techniqu
quantit
proton
mr
spectroscopi
patient
present
first
clinic
attack
ms
amount
naa
whole
brain
alreadi
decreas
indic
earli
neuron
damag
reduct
still
present
one
year
later
independ
whether
patient
progress
develop
ms
mri
techniqu
measur
brain
volum
diffus
tensor
imag
provid
variabl
result
evalu
axon
neuron
damag
especi
short
term
studi
factor
demyelin
edema
confound
result
howev
examin
neuron
integr
use
oct
show
loss
macular
volum
patient
progress
form
ms
correl
poor
visual
acuiti
especi
patient
histori
optic
neuriti
similar
axon
injuri
process
result
neuron
loss
ms
like
severalfold
direct
immun
injuri
gray
matter
result
loss
neuron
within
gray
matter
lesion
signific
increas
apoptot
neuron
observ
primarili
larg
pyramid
cortic
neuron
howev
layer
ii
primari
motor
cortex
nawm
paralbumin
interneuron
affect
neuron
rel
spare
ms
patient
differenti
suscept
neuron
expos
insult
part
key
consider
clinic
deterior
particularli
secondari
progress
relat
repeat
accumul
axon
neuron
damag
variou
neuron
popul
axon
neuron
surviv
may
directli
tie
trophic
support
provid
myelin
may
particularli
relev
high
metabol
demand
state
neuron
expos
inflammatori
stressor
summari
sever
new
featur
cellular
molecular
immun
ad
understand
patholog
ms
includ
role
b
cell
includ
antibodydepend
antibodyindepend
mechan
extent
axon
neuron
injuri
contribut
new
lineag
cell
identifi
product
leukocyt
traffick
mechan
cn
new
lymphocyt
target
diseas
stand
among
mani
recent
develop
due
space
limit
abl
cover
review
topic
involv
resolut
inflamm
ms
lesion
suppressor
cell
treg
cell
etc
remyelin
bound
import
drive
toward
comprehens
understand
pathogenesi
ms
overal
attempt
made
detail
everi
mechan
involv
patholog
ms
rather
highlight
featur
diseas
current
studi
figur
